Mesa Laboratories, Inc. (MLAB): Price and Financial Metrics


Mesa Laboratories, Inc. (MLAB): $322.44

6.75 (+2.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MLAB POWR Grades


  • Quality is the dimension where MLAB ranks best; there it ranks ahead of 82.93% of US stocks.
  • The strongest trend for MLAB is in Value, which has been heading up over the past 48 weeks.
  • MLAB ranks lowest in Value; there it ranks in the 5th percentile.

MLAB Stock Summary

  • MLAB's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 306.86 -- higher than 90.46% of US-listed equities with positive expected earnings growth.
  • MLAB's current price/earnings ratio is 405.4, which is higher than 98.29% of US stocks with positive earnings.
  • The price/operating cash flow metric for Mesa Laboratories Inc is higher than 86.72% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Mesa Laboratories Inc are RGEN, VSAT, KTOS, OMCL, and SLP.
  • Visit MLAB's SEC page to see the company's official filings. To visit the company's web site, go to www.mesalabs.com.

MLAB Valuation Summary

  • In comparison to the median Technology stock, MLAB's EV/EBIT ratio is 302.79% higher, now standing at 129.9.
  • MLAB's price/earnings ratio has moved up 336.3 over the prior 243 months.
  • MLAB's price/sales ratio has moved up 8.3 over the prior 243 months.

Below are key valuation metrics over time for MLAB.

Stock Date P/S P/B P/E EV/EBIT
MLAB 2021-09-01 10.1 3.5 345.2 129.9
MLAB 2021-08-31 10.0 3.5 342.8 128.9
MLAB 2021-08-30 10.1 3.5 346.1 130.2
MLAB 2021-08-27 10.2 3.5 348.5 131.2
MLAB 2021-08-26 10.0 3.5 344.0 129.4
MLAB 2021-08-25 10.1 3.5 345.2 129.9

MLAB Growth Metrics

  • Its 2 year net income to common stockholders growth rate is now at 145.54%.
  • Its 2 year price growth rate is now at 33.91%.
  • Its 2 year cash and equivalents growth rate is now at 1388.02%.
Over the past 52 months, MLAB's revenue has gone up $45,251,000.

The table below shows MLAB's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 138.916 44.594 4.052
2021-03-31 133.937 37.073 3.274
2020-12-31 130.181 31.956 -2.518
2020-09-30 127.664 32.031 -2.606
2020-06-30 121.34 27.903 -2.223
2020-03-31 117.687 26.559 1.349

MLAB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MLAB has a Quality Grade of B, ranking ahead of 82.5% of graded US stocks.
  • MLAB's asset turnover comes in at 0.229 -- ranking 64th of 75 Measuring and Control Equipment stocks.
  • HURC, MSON, and BRKR are the stocks whose asset turnover ratios are most correlated with MLAB.

The table below shows MLAB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.229 0.640 0.051
2021-03-31 0.224 0.650 0.054
2020-12-31 0.236 0.619 0.023
2020-09-30 0.254 0.584 0.026
2020-06-30 0.268 0.567 0.023
2020-03-31 0.337 0.552 0.060

MLAB Price Target

For more insight on analysts targets of MLAB, see our MLAB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $301.67 Average Broker Recommendation 1.67 (Moderate Buy)

MLAB Stock Price Chart Interactive Chart >

Price chart for MLAB

MLAB Price/Volume Stats

Current price $322.44 52-week high $325.50
Prev. close $315.69 52-week low $232.88
Day low $315.79 Volume 37,900
Day high $322.91 Avg. volume 26,340
50-day MA $282.94 Dividend yield 0.2%
200-day MA $270.97 Market Cap 1.68B

Mesa Laboratories, Inc. (MLAB) Company Bio


Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The company was founded in 1982 and is based in Lakewood, Colorado.


MLAB Latest News Stream


Event/Time News Detail
Loading, please wait...

MLAB Latest Social Stream


Loading social stream, please wait...

View Full MLAB Social Stream

Latest MLAB News From Around the Web

Below are the latest news stories about Mesa Laboratories Inc that investors may wish to consider to help them evaluate MLAB as an investment opportunity.

Mesa Labs To Acquire Agena Bioscience For $300 Mln Cash - Quick Facts

(RTTNews) - Mesa Laboratories, Inc. (MLAB) announced Tuesday that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments. Mesa expects to finance the all-cash transaction with a combination of cash on hand and proceeds from its

Business Insider Markets | September 14, 2021

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa or the Company), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. (Agena) for a cash purchase price of $300 million, subject to customary purchase price adjustments.

Intrado Digital Media | September 14, 2021

Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M

Mesa Laboratories Inc (NASDAQ: MLAB) has agreed to acquire Agena Bioscience Inc for a cash purchase price of $300 million. The San Diego, California-based Agena offers genetic analysis solutions to clinical labs and development partners. Excluding the impact of COVID-19 related revenues, Agena is expected to add $63 million - $67 million of revenues during the first 12 months of ownership. Agena is also expected to deliver an additional $3 million - $5 million of COVID-19 related revenues. Peter

Yahoo | September 14, 2021

Mesa Labs (MLAB) Moves 4.5% Higher: Will This Strength Last?

Mesa Labs (MLAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Yahoo | September 14, 2021

Biological Indicators Market Analysis and Global Outlook 2021 to 2026 - 3M, Getinge Group, Cantel Medical, Mesa Laboratories

The Biological Indicators Market research report provides detailed observation of several aspects, including the rate of growth, regional scope and recent developments by the primary market players. The report offers Porters Five Forces, PESTEL, and market analysis to provide a

OpenPR | September 13, 2021

Read More 'MLAB' Stories Here

MLAB Price Returns

1-mo 20.02%
3-mo 18.24%
6-mo 32.84%
1-year 34.28%
3-year 72.86%
5-year 183.86%
YTD 12.69%
2020 15.22%
2019 20.01%
2018 68.27%
2017 1.74%
2016 24.12%

MLAB Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MLAB Dividend History

Continue Researching MLAB

Here are a few links from around the web to help you further your research on Mesa Laboratories Inc's stock as an investment opportunity:

Mesa Laboratories Inc (MLAB) Stock Price | Nasdaq
Mesa Laboratories Inc (MLAB) Stock Quote, History and News - Yahoo Finance
Mesa Laboratories Inc (MLAB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9228 seconds.